Abstract:Background: A record number of people survived Ebola virus infection in the 2013-16 outbreak in west Africa, and the number of survivors has increased after subsequent outbreaks. A range of post-Ebola sequelae have been reported in survivors, but little is known about subsequent mortality. We aimed to investigate subsequent mortality among people discharged from Ebola treatment units. Methods: From Dec 8, 2015, Surveillance Active en ceinture, the Guinean national survivors' monitoring programme, attempted to contact and follow-up all survivors of Ebola virus disease who were discharged from Ebola treatment units. Survivors were followed up until Sept 30, 2016, and deaths up to this timepoint were recorded. Verbal autopsies were done to gain information about survivors of Ebola virus disease who subsequently died from their closest family members. We calculated the age-standardised mortality ratio compared with the general Guinean population, and assessed risk factors for mortality using survival analysis and a Cox proportional hazards regression model. Findings: Of the 1270 survivors of Ebola virus disease who were discharged from Ebola treatment units in Guinea, information was retrieved for 1130 (89%). Compared with the general Guinean population, survivors of Ebola virus disease had a more than five-times increased risk of mortality up to Dec 31, 2015 (age-standardised mortality ratio 5·2 [95% CI 4·0-6·8]), a mean of 1 year of follow-up after discharge. Thereafter (ie, from Jan 1-Sept 30, 2016), mortality did not differ between survivors of Ebola virus disease and the general population. (0·6 [95% CI 0·2-1·4]). Overall, 59 deaths were reported, and the cause of death was tentatively attributed to renal failure in 37 cases, mostly on the basis of reported anuria. Longer stays (ie, equal to or longer than the median stay) in Ebola treatment units were associated with an increased risk of late death compared with shorter stays (adjusted hazard ratio 2·62 [95% CI 1·43-4·79]). Interpretation: Mortality was high in people who recovered from Ebola virus disease and were discharged from Ebola treatment units in Guinea. The finding that survivors who were hospitalised for longer during primary infection had an increased risk of death, could help to guide current and future survivors' programmes and in the prioritisation of funds in resource-constrained settings. The role of renal failure in late deaths after recovery from Ebola virus disease should be investigated. Funding: WHO, International Medical Corps, and the Guinean Red Cross.

Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013–2016

Recurrent outbreaks of Ebola Virus Disease in Africa: A Meta-analysis of case fatality rates

Impact of recurrent outbreaks of Ebola virus disease in Africa: a meta-analysis of case fatality rates.

Exposure patterns driving Ebola transmission in West Africa: a retrospective observational study

The Ebola outbreak, 2013–2016: old lessons for new epidemics

Subsequent mortality in survivors of Ebola virus disease in Guinea: a nationwide retrospective cohort study

The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study

Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections

Forecasting and Uncertainty in Modeling the 2014-2015 Ebola Epidemic in West Africa

Determinants of Patient Survival During the 2014 Ebola Virus Disease Outbreak in Bong County, Liberia

Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness

Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary Analyses.

Epidemiology of Ebola virus disease in the Western area region of Sierra Leone, 2014–2015

Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

Methodological issues of retrospective surveys for measuring mortality of highly clustered diseases: case study of the 2014–16 Ebola outbreak in Bo District, Sierra Leone

A Modified SEIR Model for the Spread of Ebola in Western Africa and Metrics for Resource Allocation

Estimating the reproduction number of Ebola virus (EBOV) during the 2014 outbreak in West Africa

A Meta-Analysis of Clinical Studies Conducted During the West Africa Ebola Virus Disease Outbreak Confirms the Need for Randomized Control Groups

Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014–2016 Outbreak in West Africa